Moore Capital Management, LP Karyopharm Therapeutics Inc. Transaction History

Moore Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $432,000 - $643,000	-100,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $851,500 - $1.06 Million	-50,000 Reduced 33.33%	100,000 $1.7 Million
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $1.8 Million - $2.98 Million	150,000 New	150,000 $2.55 Million

120

64.9M

500K

99K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $60.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.